Skip to main content
. 2020 Jul 6;17(13):4854. doi: 10.3390/ijerph17134854

Figure 2.

Figure 2

Luciferase-labeled mOMSCs remain viable in the wound area. In vivo bioluminescence imaging of mice 1, 7, and 14 days following administration of Luciferase-labeled mOMSCs to the wound. In this assay, only viable cells express luciferase, which emits light following chemical conversion of luciferin, allowing monitoring of the viability, location, and concentration of the luciferase-labeled cells.